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Abstract
The forced oscillation technique（FOT）, which requires breathing without forced action, is 
a useful tool that can measure respiratory impedance.  We investigated the physiological 
differences between asthma with smoking-unrelated airflow limitation and asthma-chronic 
obstructive pulmonary disease（COPD）overlap（ACO）using the FOT.  Among 275 patients 
with asthma who presented at the Showa University Hospital from April 2018 through March 
2019, 211 were enrolled and assigned into the asthma（BA）, asthma with airflow limitation
（AL）, or ACO groups.  Respiratory impedance measured using the FOT were compared 
among the groups.  There were no significant differences in spirometry data between the AL 
and the ACO group.  The AL group had higher respiratory resistance at 5 Hz（R5）, 20 Hz
（R20）, and reactance at 5 Hz than the ACO group, but there was no significant difference in 
subtracting R20 from R5（R5-R20）.  R5 and R20 were similar between the ACO and the 
BA groups, but R5-R20, resonant frequency（Fres）, and low-frequency reactance area were 
significantly higher in the ACO group than the BA group.  Fres yielded the highest area under 
the curve（AUC）to identify airflow limitation, and R20 yielded the highest AUC to identify 
the ACO group among patients with airflow limitation.  An analysis using the cut off value to 
identify airflow limitation and ACO detected 33 patients as having ACO, 17 of whom were 
diagnosed with ACO.  R5 and R20 measured by FOT are higher in AL than in ACO despite 
no difference in spirometry data, and are not significantly different between BA and ACO.  
Therefore, FOT aids our understanding of the physiological characteristics and provides clues 
for the treatment in asthmatics with airflow limitation.
Key words :  forced oscillation technique, asthma and COPD overlap, respiratory resistance, 
airflow limitation
Introduction
　Asthma is characterised by eosinophil-based chronic 
airway inflammation and reversible airflow limitation, 
defined by a sustained decrease in a forced expiratory 
volume in 1 second / forced vital capacity（FEV1 /
FVC：FEV1％）of＜ 70％.  Airflow limitation in 
asthma is commonly due to contraction of airway 
smooth muscle and structural changes such as increased 
thickness and fibrosis of the airway smooth muscle, 
which may cause irreversible obstruction1，2.  Currently, 
the prevention and treatment of airflow limitation 
remains a challenge for clinicians3.
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　In asthma, the airflow limitation causes dyspnea on 
exertion, and its treatment and management remain 
a challenge to this day.  In Japan, asthma patients 
whose airflow limitation is thought to be induced by 
tobacco smoke are diagnosed with asthma-COPD 
overlap（ACO）4.  However, some asthmatic patients 
develop airflow limitation and exhibit clinical signs and 
symptoms similar to COPD patients such as dyspnea on 
exertion, despite not smoking or having smoked only a 
small amount.  Understanding the pathophysiology of 
this development of airflow limitation is important for 
proper application of treatment modalities and avoidance 
of persistent airflow limitation.
　The forced oscillation technique（FOT）can assess 
both proximal and peripheral airway dynamics 
by taking advantage of the low frequencies that 
propagate down the small airways5.  Because it 
requires breathing without forced action, the FOT is 
a helpful tool that can measure respiratory impedance
（Zrs）for people who have difficulty with spirometry, 
such as those with decreased lung function, the 
elderly, and children6-8.  The FOT is a non-invasive 
procedure that uses sine waves at 2-3 simultaneous 
frequencies to measure the lung mechanics shown by 
Zrs.  Respiratory resistance（Rrs）, measured by FOT, 
is the real part of Zrs, while respiratory reactance
（Xrs）is the theoretical part of Zrs9.  Rrs includes 
resistance at 5 Hz（R5）, 20 Hz（R20）, and subtracting 
R20 from R5（R5-R20）, while Xrs include reactance 
at 5 Hz（X5）, low-frequency reactance area（ALX）, 
and resonant frequency（Fres）.  The explanations of 
each parameters are shown in Table 19-12.
　Mori et al. demonstrated the potential for the FOT 
to differentiate between COPD and asthma patients, 
and that more differences between the inspiratory 
and expiratory X5（ΔX5）were observed in COPD 
than in asthma13.  A previous study showed that the 
FOT pattern of asthmatics included a moderately high 
Zrs over the entire frequency range when compared 
with healthy subjects14.  Another study showed a 
further negative change in X5 during expiration in 
severe COPD patients, whereas no significant changes 
were observed in healthy never-smokers and asthma 
patients, even in patients with FEV1％＜ 70％10.  The 
difference in the FOT results between asthma with 
airflow limitation and ACO is not fully understood. 
We conducted a retrospective study using the FOT 
to determine the differences in asthma, asthma with 
airflow limitation, and ACO.
Methods
Study design and patients
　We conducted a single-center, retrospective, case-
control study.  Data were collected from 275 patients 
with asthma who presented at Showa University 
Hospital（Tokyo, Japan）from April 2018 through 
March 2019.  Of these, 64 patients were excluded 
because they had no FOT data during the previous 
year.  The remaining 211 patients were divided into 
three groups: the asthma（BA, n＝67）, asthma with 
airflow limitation（AL, n＝78）, and ACO（n＝
66）.  Patient data were retrospectively reviewed to 
obtain clinical characteristics, including diagnosis, age, 
sex, body weight, height, body mass index（BMI）, 
smoking history, and laboratory data.  A diagnosis of 
asthma was made on a patient’s history and symptoms, 
based on the Global Initiative for Asthma15.  BMI 
was calculated as weight in kilograms divided by the 
square of the height in meters.  ACO was diagnosed 
based on the “Asthma and COPD overlap diagnosis 
and treatment guideline 2018”4.  Patients with asthma 
who showed persistent airflow limitation（FEV1％＜
70％ after inhalation of short-acting β2 agonists）, 
but did not meet the criteria for ACO diagnosis 
were categorised into the AL group.  The protocol 
was approved by the ethics committee of Showa 
Table 1.  FOT parameters
Abbr Full name Interpretation
Zrs respiratory impedance including Rrs, Xrs9
Rrs respiratory resistance reflecting airway diameter, including R5 and R2010
Xrs respiratory reactance reflecting elasticity of lung, including X5, Fres, ALX10
R5 respiratory resistance at 5 Hz resistance of entire airway11,12
R20 respiratory resistance at 20 Hz resistance of large airway11,12
R5-R20 subtracting R20 from R5 resistance of small airway11,12
X5 respiratory reactance at 5 Hz elastic recoil in the peripheral airways11
Fres resonant frequency elastic recoil in the peripheral airways11
ALX low-frequency reactance area elastic recoil in the peripheral airways11
Abbr, abbreviation.
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University School of Medicine（Approval number：
3272）, and informed consent was obtained in the 
form of opt-out on the web-site.  This study was 
performed in accordance with the principles of the 
Declaration of Helsinki.  
Spirometry
　Respiratory function in all subjects was assessed 
using a spirometer（CHESTAC-8900, Chest MI, Inc., 
Tokyo, Japan）.  The forced expiration maneuvre 
was conducted while the subject was in a standing 
position.  Predicted values for FEV1 and FVC were 
derived using local reference data from the Japanese 
Respiratory Society16.
FOT
　Zrs values were evaluated using FOT（Mostgraph-01, 
Chest MI, Inc., Tokyo, Japan）in all subjects, and all 
assessments were performed by a trained laboratory 
technologist.  In cases where both respiratory 
function tests were to be performed at the same 
time, FOT was performed before spirometry to 
avoid bronchospasm caused by intense exhalation 
and inspiration.  The subjects were instructed to 
sit, slightly extend their neck, and to place the 
mouthpiece in their mouth and make sure that there 
is no space between the lips and mouthpiece.  All 
subjects wore nose clips and held their cheeks firmly 
with their hands during the impedance measurement. 
The measurement was performed three times, in 
succession, and the best results were used.  We 
accepted resting tidal volumes of coherence of at 
least 0.7 and excluded values when resting tidal 
volumes were unstable due to coughing, swallowing, 
vocalization, and breath holding11.
Fractional exhaled nitric oxide（FeNO）
　FeNO, which indicates airway eosinophilic inflammation17, 
was measured using a portable device（NIOX MINO, 
Aerocrine AB, Solna, Sweden）at an expiratory flow 
rate of 50 ml / s for 10 s.
Statistical analyses 
　The results are expressed as the mean± standard error 
of the mean for continuous variables.  All analyses were 
performed using JMP system version 14（SAS Institute 
Inc., Cary, NC, USA）.  The differences in continuous 
variables were analyzed using the Kruskal-Wallis test. 
Differences between two groups were evaluated using 
the Mann-Whitney U test with Bonferroni’s post-hoc 
correction.  The differences in categorical variables were 
analyzed using Pearson χ2 tests.  To detect ACO using 
FOT in patients with FEV1％＜ 70％, receiver operating 
characteristic（ROC）curves were analyzed18, 19.  The 
value that maximizes sensitivity-（1-specificity）was 
set as the cut off value.  A value of P＜ 0.05 was 
considered statistically significant.  In the case of 
Bonferroni’s post-hoc test, a value of P＜ 0.017（a 




　Table 2 shows the characteristics of the study 
patients.  There were no significant differences in 
BMI, eosinophil count, Dermatophagoides pteronyssinus 
specific Immunoglobulin E（IgE）, and asthma control 
test（ACT）scores between the groups.  The mean 
age was younger in the BA group than the other 
two groups（vs AL, P＜ 0.001；vs ACO, P＜ 0.001）
and more patients were male in the ACO group 
than the other two groups（vs BA, P＜ 0.001；vs 
AL, P＜ 0.001）.  Smoking frequency and status were 
significantly higher in the ACO group than in the 
other two groups, but no different between the BA 
and AL groups.  FeNO levels and total IgE were 
not significantly different between the AL and the 
ACO groups.  There were no significant differences in 
medication step, the number of inhaled corticosteroids 
users, and the number of long-acting beta-agonist 
users between the groups.  More patients were 
administered STEP1 medication in the ACO group 
than in the other groups（BA, AL, ACO；3.0％, 
2.5％, 10.6％；respectively）.  Long-acting muscarinic 
antagonist users were higher in the ACO group 
than in the other groups（BA, AL, ACO；7.5％, 
17.9％, 50.0％；respectively）.  The number of biologic 
users, who were using omalizumab, mepolizumab, 
benralizumab, or dupilumab, was significantly higher in 
the AL group than in the ACO groups（AL, ACO；
20.5％, 6.0％；respectively）.
Spirometry data
　Spirometry data are shown in Table 3.  There were 
no significant differences in ％FVC between the groups. 
No significant differences were observed in all variables 
except for FVC and peak expiratory flow rate, which 
were not adjusted by gender, age and height, between 
the AL and ACO groups.  BA group had a higher 
％FEV1 than the AL and ACO groups（vs AL, P
＜ 0.001；vs ACO, P＜ 0.001）, but there was no 
significant difference between the AL and ACO groups
（P＝0.151）.  All variables except for FVC were 
significantly different between the BA and AL groups.
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Table 2.  Characteristics of the 211 patients with BA, AL, and ACO 
Characteristics BA（n＝67） AL（n＝78） ACO（n＝66）
P-value
BA vs AL BA vs ACO AL vs ACO
Age : years 54.2±14.6 65.5±13.5 66.8±11.3 ＜ 0.001＊ ＜ 0.001＊    0.812
Male : n（％） 20（29.8） 29（37.1） 54（81.8）    0.276 ＜ 0.001＊ ＜ 0.001＊
BMI : kg/m2 23.2±4.2 23.2±3.0 23.8±3.1 - - -
Smoking frequency : pack-years 3.2±9.4 0.8±2.1 38.9±30.6    0.766 ＜ 0.001＊ ＜ 0.001＊
Smoking status C/Ex/N : n（％）
    3（ 4.5）/








   0.788 ＜ 0.001＊ ＜ 0.001＊
cedar pollinosis : n（％） 51（76.1） 39（50.0） 11（16.6）     0.001＊ ＜ 0.001＊    0.051
Eosinophil count : /µl 290±228 479±455 320±236 - - -
IgE : IU/mL 878.4±2747.4 675.9±1105.5 1156.1±1859.1    0.403     0.003＊    0.021
Der p-specific IgE positive : n（％） 39（58.2） 39（50.0） 32（48.4） - - -
FeNO : ppb 45.9±40.5 62.6±49.0 54.5±41.5     0.006＊    0.178    0.349
ACT: point 21.1±3.6 20.7±3.6 20.2±3.1 - - -

















Biologics : n（％）  6（ 9.0） 16（20.5）  4（ 6.0）    0.049    0.526     0.011＊
ICS : n（％） 65（97.0） 76（97.4） 59（89.3） - - -
LABA : n（％） 51（76.1） 62（79.4） 60（90.9） - - -
LAMA : n（％）  5（ 7.5） 14（17.9） 33（50.0）    0.063 ＜ 0.001＊ ＜ 0.001＊
BA, asthma ; AL, asthma with airflow limitation ; ACO, asthma-COPD overlap ; BMI, body mass index ; C, current smoker ; 
Ex, ex-smoker ; N, never smoker ; Der p, Dermatophagoides pteronyssinus ; IgE, Immunoglobulin E ; FeNO, fractional 
exhaled nitric oxide ; ACT, asthma control test ; ICS, inhaled corticosteroids ; LABA, long-acting beta-agonists ; LAMA, long-
acting muscarinic antagonist. Values are mean± standard error of the mean. ＊P＜ 0.017
Table 3.  Comparisons of variables measured by spirometry between BA, AL, and ACO
Parameters BA（n＝67） AL（n＝78） ACO（n＝66）
P-value
BA vs AL BA vs ACO AL vs ACO
FVC, L 3.13±0.82 2.93±0.86 3.42±0.87    0.133    0.062  0.002＊
％FVC, ％predicted 102.3±17.7 102.0±15.7 102.2±18.8 - - -
FEV1, L/sec 2.48±0.70 1.73±0.60 1.91±0.67 ＜ 0.001＊ ＜ 0.001＊ 0.130
％FEV1, ％predicted 97.3±15.4 74.8±16.5 70.8±20.6 ＜ 0.001＊ ＜ 0.001＊ 0.151
FEV1％, ％predicted 79.2±6.5 58.6±8.24 55.8±11.3 ＜ 0.001＊ ＜ 0.001＊ 0.384
PEF, L/s 7.16±1.90 5.29±1.91 6.03±1.90 ＜ 0.001＊     0.006＊  0.016＊
V50, L/s 2.19±1.21 0.98±0.49 1.06±0.63 ＜ 0.001＊ ＜ 0.001＊ 0.782
％V50, ％ 79.9±26.6 30.7±12.5 30.4±16.5 ＜ 0.001＊ ＜ 0.001＊ 0.659
V25, L/s 0.88±0.63 0.23±0.13 0.24±0.14 ＜ 0.001＊ ＜ 0.001＊ 0.444
％V25, ％ 59.6±28.8 21.2±10.7 20.2±10.2 ＜ 0.001＊ ＜ 0.001＊ 0.466
V50/V25 3.94±1.43 4.56±1.71 4.31±1.45     0.015＊    0.086 0.429
BA, asthma; AL, asthma with airflow limitation; ACO, asthma-COPD overlap; FVC, forced vital capacity; ％FVC, ％forced 
vital capacity; FEV1, forced expiratory volume in 1 second; ％FEV1, ％ forced expiratory volume in 1 second; FEV1％, 
forced expiratory volume in 1 second / forced vital capacity; PEF, peak expiratory flow rate; V50, Expiratory flow at 50％ 
lung volume; V25, Expiratory flow at 25％ lung volume. Values are mean± standard error of the mean. ＊P＜ 0.017 




　Average Zrs levels as measured by FOT are 
shown in Table 4.  All variables were significantly 
higher in the AL group than in the BA group. 
The ACO group had significantly higher Xrs（X5, 
Fres, and ALX）and R5-R20 than the BA group. 
However, R5 and R20 were not significantly different 
between the groups.  The AL group had higher 
R5, R20, and X5 values than the ACO group, but 
no significant difference was observed in R5-R20 
between the groups.  Based on these results, R5 and 
R20 at the expiratory and inspiratory phases were 
compared between the AL and ACO groups.  R5 
was significantly higher in the AL group than in 
the ACO group in the inspiratory phase and the 
average phase（R5 AVE, P＜ 0.001；R5 In, P＝
0.005）（Figure 1A, C）.  There were no significant 
differences in any phase of R5 between the BA 
and ACO groups（Figure 1A, B, C）.  In all phases, 
R20 was significantly higher in the AL group than in 
the ACO group（R20 AVE, P＝0.001；R20 In, P＝
0.010；expiratory R20, P＜ 0.001）（Figure 1D, E, F）. 
There were no significant differences in any phase 
of R20 between the BA and ACO groups（Figure 
1D, E, F）.  These results indicate that the patients 
in the AL group have a more proximal airway 
obstruction than those in the ACO group.  Table 
S1 shows the differences between the inspiratory 
and expiratory phases of Zrs（ΔZrs）.  There were 
significant differences in ΔXrs（ΔX5, ΔFres, and 
ΔALX）, but there were no significant differences 
either in ΔRrs（ΔR5, ΔR20, and ΔR5-R20）
between the three groups.  No significant differences 
were observed in any ΔXrs between the AL and 
ACO groups.
Table 4.  Comparisons of variables measured by FOT between BA, AL, and ACO
Parameters BA（n＝67） AL（n＝78） ACO（n＝66）
P-value
BA vs AL BA vs ACO AL vs ACO
R5 AVE : cmH2O/l/s      3.49±1.61      4.50±1.64      3.73±1.26 ＜ 0.001＊     0.102  0.005＊
R20 AVE : cmH2O/l/s      2.85±1.07      3.38±1.05      2.83±0.83 ＜ 0.001＊     0.697  0.001＊
R5-R20 AVE : cmH2O/l/s      0.63±0.63      1.12±0.67      0.90±0.52 ＜ 0.001＊ 　   0.001＊ 0.060
X5 AVE : cmH2O/l/s －0.66±0.92 －1.66±1.60 －1.04±1.05 ＜ 0.001＊ 　   0.004＊  0.015＊
Fres AVE : Hz      8.39±3.60      12.9±5.44      11.2±4.67 ＜ 0.001＊ ＜ 0.001＊ 0.054
ALX AVE : cmH2O/l/s x Hz      3.79±7.87      11.9±15.2      7.26±8.84 ＜ 0.001＊ 　   0.001＊ 0.433
FOT, forced oscillation technique; BA, asthma; AL, asthma with airflow limitation; ACO, asthma-COPD overlap; AVE; 
average; R5, respiratory system resistances at 5 Hz; R20, respiratory system resistances at 20 Hz; R5-R20, subtracting R20 
from R5; X5, respiratory system reactance at 5 Hz; Fres, resonant frequency; ALX, low-frequency reactance area. Values 
are mean±standard error of the mean. ＊P＜ 0.017
Fig. 1.   Comparisons of R5 and R20 among BA, AL 
and ACO groups
Average R5（A）, expiratory R5（B）, inspiratory R5（C）, 
average R20（D）, expiratory R20（E）, and inspiratory 
R20（F）were measured by FOT. Comparisons 
among the three groups were made with the Kruskal-
Wallis test. Comparisons between two groups were 
made with Mann-Whitney U test with Bonferroni’s post-
hoc correction. R5, respiratory system resistances at 
5 Hz ; R20, respiratory system resistances at 20 Hz ; 
BA, asthma; AL, asthma with airflow limitation; ACO, 
asthma-COPD overlap; AVE; average; Ex, expiratory ; 
In, inspiratory. ＊P＜ 0.017 vs AL.
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Association between FOT and FEV1％＜ 70％ 
　Since FOT does not require forced maximal breathing, 
it will be beneficial for people who experience dyspnea 
during forced breathing, such as in COPD patients. 
ROC curve analysis of the FOT variables was used to 
identify airflow limitation.  The accuracy of the FOT 
variables for the identification of FEV1％＜ 70％ is 
shown in Table 5.  Fres yielded the highest AUC 
value（0.724）, making it the most closely associated 
variable with an FEV1％＜ 70％.  The optimum cut 
off frequency was 10.71 Hz, with 56.9％ sensitivity and 
79.1％ specificity.  The positive predictive value was 
85.4％ and the negative predictive value was 46.0％.
Association between FOT and ACO
　ROC curve analysis of FOT variables was used to 
identify ACO in patients with an FEV1％＜ 70％.  The 
accuracy of the FOT variables is shown in Table 6. 
Although there were a few differences in AUC, R20 
yielded the highest AUC value（0.654）with statistically 
significant differences, suggesting that it was the variable 
most closely associated with ACO.  The optimum cut 
off point was 3.33 kPa/l/s, with 71.2％ sensitivity and 
56.4％ specificity.  The positive predictive value was 
58.0％, and the negative predictive value was 69.8％.
Detection of ACO by FOT
　The results of ACO detection using Fres and the R20 
cut-off point obtained in this study are shown in Figure 
2.  We first used Fres for detection of FEV1％＜  
70％, followed by R20 for detection of ACO.  There 
were 96 patients with Fres ≥ 10.71 Hz（BA, AL, 
ACO：n＝14, n＝47, n＝35, respectively）, 82（85.4％）
of whom were FEV1％＜ 70％.  Of the 96 patients, 
33 had an R20 ≤ 3.33 kPa/l/s（BA, AL, ACO：n＝
6, n＝10, n＝17, respectively）and were assigned to 
Supplement material
Table S1.  Comparisons of the differences between inspiratory and expiratory Zrs between BA, AL, and ACO
Parameters BA（n＝67） AL（n＝78） ACO（n＝66）
P-value
BA vs AL BA vs ACO AL vs ACO
ΔR5 : cmH2O/l/s 　0.944±0.954 0.971±0.999 　 1.00±0.902 - - -
ΔR20 : cmH2O/l/s 　0.476±0.528 0.410±0.607 　0.467±0.582 - - -
ΔR5-R20 : cmH2O/l/s 　0.479±0.485 0.560±0.533 　0.526±0.425 - - -
ΔX5 : cmH2O/l/s －0.271±1.11 －1.01±1.92 －0.698±1.32 　   0.002＊ 0.007＊ 0.7003
ΔFres : Hz 　1.11±3.31 2.97±3.81 　2.58±3.96 ＜ 0.001＊ 0.011＊ 0.4249
ΔALX : cmH2O/l/s x Hz 　2.96±11.8 10.4±19.6 　6.70±12.4 ＜ 0.001＊ 0.001＊ 0.427
Zrs, respiratory impedance; Ex, expiratory; In, inspiratory; BA, asthma; AL, asthma with airflow limitation; ACO, asthma-
COPD overlap ; R5, respiratory system resistances at 5 Hz; R20, respiratory system resistances at 20 Hz; R5-R20, 
subtracting R20 from R5; X5, respiratory system reactance at 5 Hz; Fres, resonant frequency; ALX, low-frequency reactance 
area. Values are mean± standard error of the mean. ＊P＜ 0.017




cut off P-value Sensitivity Specificity PPV NPV
R5 AVE : cmH2O/l/s 0.646 0.563-0.721 　4.19 　  0.005＊ 0.500 0.776 0.827 0.419
R20 AVE : cmH2O/l/s 0.598 0.514-0.676 　3.01    0.072 0.555 0.656 0.776 0.407
R5-R20 AVE : cmH2O/l/s 0.695 0.614-0.766 　0.77 ＜ 0.001＊ 0.625 0.746 0.841 0.480
X5 AVE : cmH2O/l/s 0.698 0.619-0.767 －0.78 ＜ 0.001＊ 0.569 0.761 0.836 0.451
Fres AVE : Hz 0.724 0.648-0.789  10.71 ＜ 0.001＊ 0.569 0.791 0.854 0.460
ALX AVE : cmH2O/l/s x Hz 0.707 0.629-0.775 　6.66 　  0.001＊ 0.423 0.895 0.897 0.419
FOT, forced oscillation technique; FEV1％ , forced expiratory volume in 1 second/ forced vital capacity; BA, asthma; 
AL, asthma with airflow limitation; ACO, asthma-COPD overlap; AUC, area under the curve; R5, respiratory system 
resistance at 5 Hz; R20, respiratory system resistance at 20 Hz; R5-R20, subtracting R20 from R5 ; X5, respiratory 
system reactance at 5 Hz; Fres, resonant frequency; ALX, reactance area; PPV, positive predicted value; NPV, 
negative predicted value. Values are mean±standard error of the mean. ＊P＜ 0.05. 
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ACO, 17 of whom were diagnosed with ACO.  The 
positive predictive value was 51.5％.
Discussion
　This study investigated the physiological differences 
in FOT results in patients with asthma, asthma with 
airflow limitation, and ACO.  R5, R20 and X5 were 
significantly increased in the AL group compared with 
those in the ACO group, but no significant difference 
was observed in R5-R20 between these groups. 
Although most of the FOT variables showed higher 
airway resistance in the ACO group than in the BA 
group, R5 and R20 were similar between these groups.
　It is important to determine the differences in 
FOT results to investigate the physiological differences 
between patients with different types of asthma, 
particularly when multiple types involve obstructive 
pulmonary function.  Zrs was higher in patients with 
asthma than in healthy subjects and was positively 
correlated with pulmonary function14.  In this study, the 
degree of airflow limitation measured by spirometry 
was similar between the AL and ACO groups, whereas 
most of the FOT variables, particularly R5, R20, and 
X5, were higher in the AL group compared with 
the ACO group.  A previous study conducted by 
Kitaguchi et al. showed the similar tendencies that Rrs 
values were higher in asthma patients with airflow 
limitation compared with ACO patients20.  These data 
suggest there is higher respiratory resistance, at least 
Rrs, in AL patients than those in ACO patients.  A 
prospective research with a larger number of patients 
is needed to confirm this hypothesis.
　A previous study reported that R20 correlates with 
proximal airway resistance, and R5-R20 correlates with 
peripheral airway resistance12.  We showed that R5 and 
R20, but not R5-R20, were significantly higher in the 
AL group than the ACO group, suggesting that the AL 
group had higher proximal airflow limitation than the 
ACO group.  By using FOT, this study revealed that 
airflow limitation occurred at a more proximal location 
in the AL group.  Since inhaled drugs, which are the 
main treatment for asthma, reaches different parts of 
the airway depending on its particle size, it may be 
possible to prevent future airflow limitation by selecting 
the inhaled drug according to the obstructed part of 
the airway.  Additionally, although most of the FOT 




cut off P-value Sensitivity Specificity PPV NPV
R5 AVE : cmH2O/l/s 0.634  0.281-2.32 4.12 0.02＊ 0.636 0.628 0.591 0.671
R20 AVE : cmH2O/l/s 0.654  0.536-2.91 3.33 ＜ 0.001＊ 0.712 0.564 0.580 0.698
R5-R20 AVE : cmH2O/l/s 0.590 －0.197-1.10 1.48 0.029 0.893 0.294 0.517 0.766
X5 AVE : cmH2O/l/s 0.617 －0.171-0.789 －0.48 0.011 0.439 0.782 0.630 0.622
Fres AVE : Hz 0.593 －0.216-1.50 7.83 0.045 0.363 0.807 0.615 0.600
ALX AVE : cmH2O/l/s x Hz 0.597 －0.286-0.563 1.89 0.023 0.439 0.756 0.604 0.614
FOT, forced oscillation technique; ACO, asthma-COPD overlap; AUC, area under the curve; FEV1％, forced expiratory 
volume in 1 second / forced vital capacity; AVE; average; R5, respiratory system resistance at 5 Hz; R20, respiratory 
system resistance at 20 Hz; R5-R20, subtracting R20 from R5; X5, respiratory system reactance at 5 Hz; Fres, resonant 
frequency; ALX, reactance area; PPV, positive predicted value; NPV, negative predicted value. Values are mean±
standard error of the mean. ＊P＜ 0.05. 
Fig. 2.   Distribution of the patients classified by the cut 
off point of Fres and R20
Patients were differentiated by the cut off point of 
Fres 10.71 Hz to identify FEV1％＜ 70％, and then the 
patients whose Fres was higher than 10.71 Hz were 
differentiated by the cut off point of R20 3.33 kPa/l/s 
to identify ACO. Numbers in each bars were absolute 
numbers of patients. ACO, asthma-COPD overlap; AVE, 
average ; Fres, resonant frequency ; R20, respiratory 
system resistance at 20 Hz.
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variables had higher respiratory resistance in the ACO 
group than in the BA group, R5 and R20 were similar. 
This finding suggests that smoking exposure tends to 
induce obstructive changes in distal airways but not 
proximal airways, at least, in patients with asthma.
　Previous studies showed that ΔX5 was useful in 
differentiating between COPD and asthma12.  However, 
there were no significant differences in ΔXrs between the 
AL and ACO groups, suggesting that ΔXrs could not 
differentiate between AL and ACO in the clinical setting.
　The AL group had significantly worse spirometry and 
FOT data than the BA group.  However, there was 
no significant difference in ACT scores and medication 
steps.  A previous study reported that airflow limitation 
developed despite sufficient treatment, suggesting that 
anti-asthma medications might have minimal effects on 
airway remodeling, specifically in older patients with 
asthma3.  Meanwhile, 90％ of the AL group received 
at least step 3 treatment, and more than 50％ of the 
AL group received at least step 4 treatment or more. 
The prevalence of patients using biologics such as 
omalizumab, mepolizumab, benralizumab, and dupilumab, 
was highest in the AL group.  Thus, lower pulmonary 
function and higher Zrs in the AL group were not 
associated with insufficient treatment.  
　Fres had the highest correlation coefficient with 
FEV1％ in this study, which is consistent with 
previous reports showing that Fres is strongly 
associated with airflow limitation21，22.  This study had 
a comparatively high positive predictive value and low 
sensitivity, resulting from the low Fres cut-off point 
used.  For the detection of airflow limitation, Fres 
measured by FOT, which does not require forced 
breathing, could be a substitute for spirometry.  Fres 
has typically high values in children, and decreases 
with age, and tends to increase in both obstructive 
and restrictive disorders11.  One reason for the low 
Fres cut-off point in this study might be that many 
elderly patients were included.  In addition, the Fres 
cut-off point for FEV1％＜ 70％ would depend on 
the disease profiles within the population.  Therefore, 
background characteristics including age and disease 
profiles should be considered when determining Zrs 
cut-off values.  
　Our study has identified a few limitations.  First, 
this was a single-center retrospective study and the 
sample size was relatively small.  To confirm our 
hypothesis, a study with a large number of patients 
would be needed.  Second, all participants in this 
study were patients with asthma.  If the population 
included non-asthmatics, such as COPD patients and 
healthy control individuals, the Zrs cut off values for 
identification of FEV1％＜ 70％ would be different. 
Third, previous report showed that low FEV1 in early 
adulthood is associated with the genesis of COPD23. 
In the patients with the AL group in this study, it 
is possible that the airflow limitation is caused by 
pulmonary growth disorder in early adulthood as 
well as COPD.  From the viewpoint of prevention 
of airflow limitation, it is necessary to examine the 
difference between the AL group and the ACO 
group regarding the longitudinal change of FOT data. 
Fourth, since this study was retrospective, computed 
tomography（CT）image data were insufficient, hence, 
a comparative study among the three groups was not 
possible.  The relationship between FOT data and 
airway diameter and emphysematous change obtained 
from CT images are uncertain.
　In conclusion, high R20 values measured by FOT 
were revealed to be the primary characteristic for 
the AL patients, compared with the ACO patients. 
Moreover, no differences were observed in R20 
between the BA and ACO patients.  Thus, FOT aids 
our understanding of the physiological characteristics 
and provides clue for treatment in asthmatics with 
airflow limitation.
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